Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancer.
Janmaat VT, Steyerberg EW, van der Gaast A, Mathijssen RH, Bruno MJ, Peppelenbosch MP, Kuipers EJ, Spaander MC.
Cochrane Database Syst Rev. 2017 Nov 28;11(11):CD004063. doi: 10.1002/14651858.CD004063.pub4.
PMID:29182797
Palliative chemotherapy.
Ellison NM.
Am J Hosp Palliat Care. 1998 Mar-Apr;15(2):93-103. doi: 10.1177/104990919801500208.
PMID:9543897
Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.
Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, Zoetmulder FA.
J Clin Oncol. 2003 Oct 15;21(20):3737-43. doi: 10.1200/JCO.2003.04.187.
PMID:14551293
Challenges and Advancements in Palliative Chemotherapy for Ampullary Adenocarcinoma.
Kim EJ.
Gut Liver. 2024 Jul 15;18(4):560-561. doi: 10.5009/gnl240283.
PMID:39005199
Palliative chemotherapy for recurrent and metastatic esophageal cancer.
Grünberger B, Raderer M, Schmidinger M, Hejna M.
Anticancer Res. 2007 Jul-Aug;27(4C):2705-14.
PMID:17695436
Chemotherapy and other supportive modalities in the palliative setting for pancreatic cancer.
Sullivan KM, Kozuch PS.
Cancer J. 2012 Nov-Dec;18(6):633-41. doi: 10.1097/PPO.0b013e318275896f.
PMID:23187852
[Palliative chemotherapy].
Osieka R.
Zentralbl Chir. 1998;123(6):714-21.
PMID:9703646
Second-line palliative chemotherapy, survival, and prognostic factors in patients with advanced pancreatic cancer.